Javier Morales
Overview
Explore the profile of Javier Morales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
542
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morales J, King A, Oser S, DSouza S
Postgrad Med
. 2024 Sep;
136(8):791-800.
PMID: 39348567
Type 2 diabetes (T2D) is a chronic condition that requires not only a team-based approach but also substantial self-management by those affected. Patient-clinician barriers such as lack of educational resources,...
2.
Handelsman Y, Anderson J, Bakris G, Ballantyne C, Bhatt D, Bloomgarden Z, et al.
Metabolism
. 2024 Jun;
159:155931.
PMID: 38852020
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and...
3.
Cordero A, Bertomeu-Gonzalez V, Segura J, Morales J, Alvarez-Alvarez B, Escribano D, et al.
Med Clin (Barc)
. 2024 May;
163(4):167-174.
PMID: 38821830
Background: Coronary heart disease is the leading cause of heart failure (HF), and tools are needed to identify patients with a higher probability of developing HF after an acute coronary...
4.
Iglesies-Torrent J, Garrido M, Morales J, Pitart C, Vergara A, Fernandez-Pittol M
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 May;
42(7):377-379.
PMID: 38705749
Introduction: Pneumococcal bacteraemia is a major contributor to global morbidity and mortality. Traditional culture-based methods lack sensitivity and are time-consuming. This study aimed to assess the effectiveness of two culture-independent...
5.
Paredes-Toledo J, Herrera J, Morales J, Robert P, Oyarzun-Ampuero F, Gimenez B
Food Chem
. 2024 Feb;
445:138828.
PMID: 38401311
The aim of this study was to evaluate the bioaccessibility of chlorogenic acid (CA) and curcumin co-encapsulated in Pickering double emulsions (DEs) with the inner interface stabilized by hydrophobically modified...
6.
Morales J, Palmer B
Postgrad Med
. 2024 Feb;
136(2):111-119.
PMID: 38344772
Chronic kidney disease (CKD) is a prevalent complication of Type II diabetes (T2D). The coexistence of CKD with T2D is comparable to cardiovascular disease (CVD) when the estimated glomerular filtration...
7.
Morales J, Dagogo-Jack S, Fonseca V, Neumiller J, Rosas S
Clin Diabetes
. 2023 Oct;
41(4):553-566.
PMID: 37849516
No abstract available.
8.
Morales J, Handelsman Y
J Am Coll Cardiol
. 2023 Jul;
82(2):161-170.
PMID: 37407115
Chronic kidney disease (CKD) and cardiovascular disease (CVD) have a significant inter-relationship in patients with diabetes. Controlling blood pressure, dyslipidemia, and glucose levels is a common treatment approach to managing...
9.
Jackson N, Ortiz A, Jerez A, Morales J, Arriagada F
Pharmaceutics
. 2023 Jun;
15(6).
PMID: 37376039
Stimuli-responsive nanomaterials have emerged as a promising strategy for inclusion in anticancer therapy. In particular, pH-responsive silica nanocarriers have been studied to provide controlled drug delivery in acidic tumor microenvironments....
10.
Plaza-Diaz J, Ruiz-Ojeda F, Morales J, Martin-Masot R, Climent E, Silva A, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108555
The World Health Organization recommends exclusive breastfeeding on demand until at least the sixth month of life. Breast milk or infant formula is the infant's primary food source until the...